TRACON Pharmaceuticals Inc (TCON)
1.79
-0.10
(-5.29%)
USD |
NASDAQ |
Apr 25, 16:00
1.78
-0.01
(-0.56%)
After-Hours: 20:00
TRACON Pharmaceuticals Total Liabilities (Quarterly): 10.91M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.91M |
| September 30, 2023 | 12.50M |
| June 30, 2023 | 27.93M |
| March 31, 2023 | 19.40M |
| December 31, 2022 | 26.62M |
| September 30, 2022 | 22.30M |
| June 30, 2022 | 13.14M |
| March 31, 2022 | 16.07M |
| December 31, 2021 | 14.84M |
| September 30, 2021 | 13.94M |
| June 30, 2021 | 14.89M |
| March 31, 2021 | 11.30M |
| December 31, 2020 | 12.37M |
| September 30, 2020 | 12.58M |
| June 30, 2020 | 12.65M |
| March 31, 2020 | 12.96M |
| December 31, 2019 | 15.42M |
| September 30, 2019 | 17.18M |
| June 30, 2019 | 19.03M |
| March 31, 2019 | 19.38M |
| Date | Value |
|---|---|
| December 31, 2018 | 19.21M |
| September 30, 2018 | 19.93M |
| June 30, 2018 | 17.96M |
| March 31, 2018 | 21.37M |
| December 31, 2017 | 19.14M |
| September 30, 2017 | 15.56M |
| June 30, 2017 | 15.60M |
| March 31, 2017 | 14.93M |
| December 31, 2016 | 17.39M |
| September 30, 2016 | 18.83M |
| June 30, 2016 | 19.81M |
| March 31, 2016 | 21.67M |
| December 31, 2015 | 22.54M |
| September 30, 2015 | 18.98M |
| June 30, 2015 | 18.87M |
| March 31, 2015 | 17.94M |
| December 31, 2014 | 70.34M |
| September 30, 2014 | 70.96M |
| December 31, 2013 | 27.76M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.91M
Minimum
Dec 2023
27.93M
Maximum
Jun 2023
16.11M
Average
14.84M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| BioSig Technologies Inc | 4.685M |
| Revolution Medicines Inc | 235.51M |
| Perspective Therapeutics Inc | 22.71M |
| Electromed Inc | 6.622M |
| Xtant Medical Holdings Inc | 41.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.10M |
| Shareholders Equity (Quarterly) | -0.809M |
| Current Ratio | 0.8928 |
| Net Debt Paydown Yield | 23.47% |